About this trial
The goal of this observational study is to investigate whether speech-in-noise perception deficits in older adults aged 60 years or older with objectively normal hearing thresholds are due to impaired ability of processing temporal cues in speech signals. The study further aims to examine whether cognitive and cortical mechanisms provide compensatory support for speech perception in challenging listening environments.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 60 years or older;
Bilateral pure-tone average hearing thresholds across 0.5, 1, 2, and 4 kHz ≤ 25 dB HL;
Self-reported hearing difficulties identified during previous hearing screening;
Fluent in Mandarin Chinese;
Disqualifiers
Unable to comply with or complete the study assessments;
Mini-Mental State Examination (MMSE) score < 24 during previous health screening;
Refuse to participate in the study
Trial population
Community-dwelling adults aged 60 years and older residing in Shanghai, who has objectively normal hearing thresholds on pure-tone audiometry but self-report difficulties understanding speech in noisy or complex listening environments.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Conventional pure-tone audiometry (PTA) with extended high-frequency (0.25-16 kHz)
This measure reflects the overall audibility of the individual. Together with the other measures listed under the primary outcome measure, it provides a comprehensive assessment of participants' peripheral auditory function.
Gap Detection Test (GDT)
This behavioral test assesses an individual's ability to detect brief silent gaps in an auditory signal, reflecting temporal resolution within the auditory system
Distortion Product Otoacoustic Emissions (DPOAEs)
This objective measure evaluates cochlear outer hair cell. Together with the other measures listed under the primary outcome measure, it provides a comprehensive assessment of participants' peripheral auditory function.
Electrocochleography
This objective measure assesses cochlear and auditory nerve function. Together with the other measures listed under the primary outcome measure, it provides a comprehensive assessment of participants' peripheral auditory function.
Secondary outcomes
Depressive symptoms assessed using the Patient Health Questionnaire-9 (PHQ-9)
Anxiety symptoms assessed using the Generalized Anxiety Disorder-7 (GAD-7)
Cognitive function assessed using Digit Span test.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.